HIMZX | VFSUX | HIMZX / VFSUX | |
Total Expense Ratio | 0.75 | 0.09 | 833% |
Annual Report Gross Expense Ratio | 0.93 | 0.09 | 1,033% |
Fund Existence | 26 years | 24 years | - |
Gain YTD | 2.974 | 1.643 | 181% |
Front Load | 2% | N/A | - |
Min. Initial Investment | 2500 | 50000 | 5% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 454M | 52.5B | 1% |
Annual Yield % from dividends | 4.30 | 4.41 | 97% |
Returns for 1 year | 6.42 | 2.64 | 243% |
Returns for 3 years | 16.04 | 3.76 | 427% |
Returns for 5 years | 13.21 | -4.11 | -322% |
Returns for 10 years | 26.47 | 6.48 | 409% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GAFFX | 82.92 | 0.81 | +0.99% |
American Funds Growth Fund of Amer F3 | |||
WFTCX | 5.21 | 0.05 | +0.97% |
Allspring Innovation Fund - Class C | |||
JOEMX | 13.50 | 0.06 | +0.45% |
JOHCM Emerging Markets Opps Instl | |||
JFNSX | 62.64 | 0.05 | +0.08% |
Janus Henderson Global Life Sciences S | |||
EUGCX | 26.12 | -0.05 | -0.19% |
Morgan Stanley Europe Opportunity L |